Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | H. A. Burris, M. S. Gordon, M. D. Hellmann, P. LoRusso, L. A. Emens, F. S. Hodi, C. H. Lieu, J. R. Infante, F. Yung-Chin Tsai, J. P. Eder, J.M. Cleary, D. Jelovac, A. L. Tsuhako, L. Mueller, R. Lin, K. Morrissey, S. Mahrus, R Morley, A. Pirzkall, S. Davis | ||||||||||||
Title | A phase Ib dose escalation study of combined inhibition of IDO1 (GDC-0919) and PD-L1 (atezolizumab) in patients (pts) with locally advanced or metastatic solid tumors. | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/199/AbstView_199_192935.html | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 105) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|